From Rabbits to Research: Samantha Kremidas Finds Her Niche at Battelle

Researchers at Battelle are working to unlock the potential of polymeric nanoparticles (PNPs) to deliver safe, effective therapies for previously untreatable conditions. In this blog, we’ll cover some of the most frequently asked questions about gene therapy and this novel delivery vehicle technology.

Battelle has developed a new polymer nanoparticle (PNP) delivery system that can target specific cell types, such as neuronal cells. The work, which was recently recognized as the “Best Poster” at the Controlled Release Society 2024 Annual Meeting in Italy, could pave the way for safer, more effective gene therapies for genetic diseases.

The EPA draft risk assessment for PFOA and PFOS in sewage sludge, explained - Including key details, analysis and fingerprinting, how Battelle can help and what's coming next.

Understand the upcoming guidance on drinking water in the EU and how it applies to plant protection products and biocides.

As companies face mounting pressure from both regulators and the public to address PFAS risks, Battelle has developed a comprehensive framework to help businesses confidently understand, quantify and manage PFAS risk.